{
    "nct_id": "NCT02305654",
    "official_title": "International Penile Advanced Cancer Trial (International Rare Cancers Initiative Study)",
    "inclusion_criteria": "1. Written informed consent\n2. Measurable disease as determined by RECIST (version 1.1) criteria;\n3. Histologically-proven squamous cell carcinoma of the penis,\n4. Stage:\n\n   * any T, N1 (i.e. a palpable mobile unilateral inguinal lymph node), M0 or;\n   * any T, N2 (i.e. palpable mobile multiple or bilateral inguinal lymph nodes), M0 or;\n   * any T, N3 (i.e. fixed inguinal nodal mass or any pelvic lymphadenopathy), M0\n5. Performance Status ECOG 0, 1 or 2.\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "1. Pure verrucous carcinoma of the penis,\n2. Nonsquamous malignancy of the penis,\n3. Squamous carcinoma of the urethra,\n4. Stage M1,\n5. Previous chemotherapy or chemoradiotherapy,\n6. Concurrent malignancy (other than SCC or Basal Cell Carcinoma of non-penile skin) that has required surgical or non-surgical treatment in the last 3 years.",
    "miscellaneous_criteria": ""
}